Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Tumor-Intrinsic RIG-I Signaling Promotes Anti-CTLA-4 Checkpoint Inhibitor-Mediated Anticancer Immunity

Simon Heidegger, MD, Alexander Wintges, Sarah Bek, Martina Schmickl, Jürgen Ruland, MD, Marcel R.M. van den Brink, MD PhD, Christian Peschel, MD, Tobias Haas, MD, Hendrik Poeck, MD

Blood (2017) 130 (Supplement 1): 693.

https://doi.org/10.1182/blood.V130.Suppl_1.693.693

Published: 2017

Journal Articles

The RIG-I Agonist 3pRNA Synergizes with Checkpoint Blockade in Cancer Immunotherapy

Simon Heidegger, MD, Diana Kreppel, Michael Bscheider, MD, Alexander Wintges, Sarah Bek, Martina Schmickl, Jürgen Ruland, MD, Christian Peschel, MD, Marcel van den Brink, MD, Tobias Haas, MD, Hendrik Poeck, MD

Blood (2015) 126 (23): 3436.

https://doi.org/10.1182/blood.V126.23.3436.3436

Published: 2015

Journal Articles

A Mouse Model for XLP-2 Disease Uncovers a Critical Function for IL-1beta and TNF in Driving Hyper-Inflammation

Philipp J. Jost, MD, Monica Yabal, PhD, Heiko Adler, PhD, Nathalie Knies, Christina Groß, Rune Busk Damgaard, Hirokazu Kanegane, MD PhD, Christian Peschel, MD, Andreas Strasser, PhD, Olaf Groß, Jürgen Ruland, MD, Mads Gyrd-Hansen, PhD

Blood (2014) 124 (21): 1403.

https://doi.org/10.1182/blood.V124.21.1403.1403

Published: 2014

Journal Articles

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

Sabine Steidle, MD, Tobias Dechow, MD, Katharina Götze, Martina Rudelius, MD, Konstanze Pechloff, PhD, Kerstin Behnke, Lars Bullinger, MD PhD, Falko Fend, MD, Soberon Valeria, PhDstudent, Marc Schmidt-Supprian, PhD, Florian Bassermann, MD, Jürgen Ruland, MD, Christian Peschel, MD, Ulrich Keller, MD

Blood (2014) 124 (21): 648.

https://doi.org/10.1182/blood.V124.21.648.648

Published: 2014

Journal Articles

MCL-1 Critically Regulates Survival Of T-Lymphocyte Non-Hodgkin Lymphoma

Sabine Spinner, Kelly Gemma, PhD, Marco Herold, PhD, Konstanze Pechloff, PhD, Giuliano Crispatzu, Jürgen Ruland, MD, Marco Herling, MD, Christian Peschel, MD, Andreas Strasser, PhD, Philipp J. Jost, MD

Blood (2013) 122 (21): 4246.

https://doi.org/10.1182/blood.V122.21.4246.4246

Published: 2013

NARROW

Tumor-Intrinsic RIG-I Signaling Promotes Anti-CTLA-4 Checkpoint Inhibitor-Mediated Anticancer Immunity

The RIG-I Agonist 3pRNA Synergizes with Checkpoint Blockade in Cancer Immunotherapy

A Mouse Model for XLP-2 Disease Uncovers a Critical Function for IL-1beta and TNF in Driving Hyper-Inflammation

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

MCL-1 Critically Regulates Survival Of T-Lymphocyte Non-Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Tumor-Intrinsic RIG-I Signaling Promotes Anti-CTLA-4 Checkpoint Inhibitor-Mediated Anticancer Immunity

The RIG-I Agonist 3pRNA Synergizes with Checkpoint Blockade in Cancer Immunotherapy

A Mouse Model for XLP-2 Disease Uncovers a Critical Function for IL-1beta and TNF in Driving Hyper-Inflammation

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

MCL-1 Critically Regulates Survival Of T-Lymphocyte Non-Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only